Anbio Biotechnology
NNNN | NASDAQ
$3.88
+$0.06 (+1.57%)
At close: Nov 16, 2026, 4:00 PM ET
$3.88
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+1.57%
(1D)No price chart data available for 1D timeframe.
Rating
78.5
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #29/1021 (Top 3%)
Key Statistics
Market Data
Market Cap $170.3M
1D Range
3.80 3.94
52W Range
3.13 41.11
Valuation (TTM)
PE 16.17
PB 5.65
EV/EBITDA 24.45
Valuation (NTM)
Forward PE N/A
Forward PEG 0.20
Price Target $0.00
Cash Flow
FCF Yield 0.0%
SBC Adj. FCF Yield 0.0%
SBC Impact N/A
Margins
Gross Margin 86.1%
Operating Margin 66.7%
FCF Margin 0.0%
Growth (CAGR)
Revenue 3Y | 5Y -28.4% |
N/A
Dil EPS 3Y | 5Y -2.6% |
N/A
FCF 3Y | 5Y -53.6% |
N/A
Returns
ROA 28.1%
ROE 27.5%
ROIC 25.5%
Financial Health
Net Cash
$11.9M
Current Ratio 344.31
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers reg...
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 27
IPO Date Feb 19, 2025
Website www.anbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NNNN